Formosa Laboratories provides one-stop CDMO services from small-molecule, polymer API, ADC (Antibody Drug Conjugates) manufacturing, formulation development to state-of-art injectable liquid filling and lyophilization for both cytotoxic and non-cytotoxic drug products.
Notably, for over 25 years, Formosa Laboratories has produced its own APIs and UV-filters in its modern facilities in Taiwan. The GMP facilities have been approved by the DOH, FDA, EDQM, PMDA, and German regulatory authorities.
Notably, for over 25 years, Formosa Laboratories has produced its own APIs and UV-filters in its modern facilities in Taiwan. The GMP facilities have been approved by the DOH, FDA, EDQM, PMDA, and German regulatory authorities.
Ticker:
4746
Exchange:
TPE: TAIEX
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Not Provided
Company HQ Country:
Taiwan
Year Founded:
1995
Main Therapeutic Focus:
Lead Product in Development:
APIs in various categories, ADC, Injectable products
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
